Diabetic Medicine

Papers
(The H4-Index of Diabetic Medicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
128
A cognitive behavioural model of the bidirectional relationship between disordered eating and diabetes self care in adult men with Type 1 diabetes mellitus124
Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study76
Letter to the editor: Nuances from the manufacturer regarding the ABCD‐DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system58
Investigating health professionals' perspectives and experiences of food security‐related conversations in diabetes care50
Utility of screening for silent myocardial ischaemia in diabetes with an annual electrocardiogram50
Issue Information49
Lack of consideration of socioeconomic factors in transition programme of adolescents with type 1 diabetes: A systematic review39
Gestational diabetes: One size does not fit all—an observational study of maternal and neonatal outcomes by maternal glucose profile38
Satisfaction with diabetes involvement: Exploring parent and adolescent perspectives35
Evaluating T cell responses prior to the onset of type 1 diabetes32
Autopsy of a telephone‐based peer support intervention: Exploring participants' perspectives of and experiences with a self‐management support model for adults with type 2 diabetes from speciality car31
Update on technologies, medicines and treatments31
Design, recruitment and baseline characteristics of the LENS trial31
Profiles of disordered eating behaviour in type 1 diabetes using the DEPS‐R and behaviour and glycaemic outcomes in a real‐life setting31
Author Index31
Associations between weight self‐stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross‐sectional results from the second Diabetes MILES – Australia (MILES‐2) study29
The impact of stigma on the management of type 1 diabetes: A systematic review29
Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review28
Exploring low‐dose glucagon for exercise‐induced hypoglycaemia in type 1 diabetes: A randomised controlled trial28
A validation study of the Intentional Nonadherence Scale among people with type 2 diabetes in the United Kingdom28
Impact of diabetes stigma in diabetes distress and diabetes self‐care: The moderating role of diabetes social support and general self‐esteem in Arabic‐speaking adults with type 2 diabetes27
Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and you26
Improving equity in diabetes technology use: Voices of youth and their parents24
Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study24
Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA 24
0.09070897102356